These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 7916559)

  • 1. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
    McMahon R; Mulligan LM; Healey CS; Payne SJ; Ponder M; Ferguson-Smith MA; Barton DE; Ponder BA
    Hum Mol Genet; 1994 Apr; 3(4):643-6. PubMed ID: 7915166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET protooncogene.
    Chi DD; Toshima K; Donis-Keller H; Wells SA
    Surgery; 1994 Aug; 116(2):124-32; discussion 132-3. PubMed ID: 7914034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
    World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes.
    Wells SA; Skinner MA
    Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Frilling A; Dralle H; Eng C; Raue F; Broelsch CE
    Surgery; 1995 Dec; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
    Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
    Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers].
    Belli S; Storani ME; Dourisboure RJ; Podestá EJ; Solano AR
    Medicina (B Aires); 2003; 63(1):41-5. PubMed ID: 12673960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations of the RET proto-oncogene in pedigree with MEN type 2A: DNA analysis and its implications for pediatric surgery.
    Shimotake T; Iwai N; Inoue K; Inazawa J; Nishisho I
    J Pediatr Surg; 1996 Jun; 31(6):779-81. PubMed ID: 8783101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H; Dou S; Chi D; Carlson KM; Toshima K; Lairmore TC; Howe JR; Moley JF; Goodfellow P; Wells SA
    Hum Mol Genet; 1993 Jul; 2(7):851-6. PubMed ID: 8103403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene.
    Tsai MS; Ledger GA; Khosla S; Gharib H; Thibodeau SN
    J Clin Endocrinol Metab; 1994 May; 78(5):1261-4. PubMed ID: 7909818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
    Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.